Inside the research
Integer Holdings Corporation
ITGR Research profile · latest available data
Price overview
$126.34
▲ +0.17 (+0.1%)
| 52w hi | $126.50 |
|---|---|
| 52w lo | $63.32 |
| Vol | 567.40K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.25
| Short | +0.36 |
|---|---|
| Medium | +0.34 |
| Long | -0.14 |
computed 2026-09-27
Key fundamentals
Integer Holdings Corporation
Healthcare · Medical Devices
| Market cap | $4.30B |
|---|---|
| Enterprise value | $5.64B |
| Trailing P/E | 34.61x |
| Forward P/E | 18.39x |
| EV / EBITDA | 16.21x |
| P / S (ttm) | 2.33x |
| Profit margin | 7.0% |
| Return on equity | 7.5% |
| Revenue growth | -2.6% |
| Earnings growth | -33.7% |
| Debt / equity | 79.39 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.04 | |
| Sector | +0.08 | |
| Technical | +0.25 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Risk Metrics
| Beta vs SPX | 0.80 |
|---|---|
| Corr SPX | 0.34 |
| Annual vol | 38.3% |
| Annual ret | +6.8% |
| Sharpe | 0.18 |
| Max DD | -56.1% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-04 | Material Agreement, Bylaws Amendment… | read |
| 2026-08-03 | Reg FD Disclosure, Exhibits | read |
| 2026-08-03 | Earnings Release, Exhibits | read |
| 2026-06-26 | Officer / Director Change | read |
| 2026-05-22 | Officer / Director Change, Shareholder Vote… | read |
| 2026-04-30 | Earnings Release, Reg FD Disclosure… | read |
| 2026-03-12 | Material Agreement, Officer / Director Change… | read |
| 2026-02-19 | Earnings Release, Reg FD Disclosure… | read |
| 2025-11-04 | Other Material Event, Exhibits | read |
| 2025-10-24 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-10-23 | Earnings Release, Reg FD Disclosure… | read |
| 2025-07-24 | Earnings Release, Reg FD Disclosure… | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Thor Kirk K | Chief Human Resources Off | Option exercise | 6.12K | — |
| 2026-06-30 | Thor Kirk K | Chief Human Resources Off | Withheld for tax | 2.41K | $225.12K |
| 2026-05-20 | MAXWELL MARTIN C | Grant | 1.97K | — | |
| 2026-05-20 | COYLE MICHAEL J | Grant | 1.97K | — | |
| 2026-05-20 | Kapito Aaron | Grant | 1.97K | — | |
| 2026-05-20 | Jeffers Alvin Tyrone | Grant | 1.97K | — | |
| 2026-05-20 | Capps Cheryl C | Grant | 1.97K | — | |
| 2026-05-20 | Antrum Sheila | Grant | 1.97K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 100.0% |
| HHI | 4,964 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Citadel Advisors | $91.49M | 979.05K |
| State Street Corp | $25.47M | 26.32M |
| Fidelity / FMR LLC | $10.97M | 11.35M |
| AQR Capital Management | $7.26M | 77.69K |
| Millennium Management | $845.91K | 875.00K |
| Capital Research / Capital World | $38.96K | 32.00K |
| T. Rowe Price Group | $4.00K | 42.77K |
As of 2026-06-30
SEC Filings
| Date | Form | Doc |
|---|---|---|
| 2026-08-04 | DEFA14A | view |
| 2026-08-04 | 8-K | view |
| 2026-08-04 | 10-Q | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | 8-K | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | DEFA14A | view |
| 2026-08-03 | 8-K | view |
| 2026-08-03 | DEFA14A | view |
| 2026-07-10 | 4 | view |
| 2026-07-10 | 3 | view |
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.56B | +8.1% | |
| Gross profit | $500.39M | +7.6% | |
| Operating income | $221.26M | +46.6% | |
| Net income | $102.81M | +9.1% | |
| Cash from ops | $196.15M | +5.7% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $126.26 | $126.35 | $126.21 | $126.34 | 567.40K |
| Sep 24 | $126.30 | $126.43 | $126.16 | $126.17 | 816.60K |
| Sep 23 | $126.40 | $126.44 | $126.28 | $126.32 | 527.90K |
| Sep 22 | $126.40 | $126.44 | $126.32 | $126.33 | 555.00K |
| Sep 21 | $126.53 | $126.53 | $126.27 | $126.38 | 685.60K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →